Brief: India's Unichem Gets 1 Observation From USFDA Inspection Of Ghaziabad Unit
Aug 26 (Reuters) - Unichem Laboratories Ltd UNLB.NS :
* U.S. FDA INSPECTED COMPANY'S GHAZIABAD FORMULATION
FACILITY
BETWEEN AUGUST 19, 2019 TO AUGUST 23, 2019
* INSPECTION WAS A ROUTINE GMP SURVEILLANCE
* AT END OF INSPECTION, FACILITY RECEIVED 1 OBSERVATION
WHICH IS
NOT A REPEAT OBSERVATION AND IS PROCEDURAL IN NATURE
Source text for Eikon: ID:nBSE4NHWYN
Further company coverage: UNLB.NS
((bangalore.newsroom@thomsonreuters.com;))
Recent news on Unichem Laboratories
See all newsIndia's Unichem Laboratories drops after US FDA inspection ends with five observations
India's Unichem Labs falls after appeal against tax demand rejected
Brief: Unichem Laboratories June-Quarter Consol PAT 414.7 Million Rupees
India's Unichem Laboratories jumps on posting Q1 profit
India's Unichem Laboratories surges in busiest session ever after block deal at premium